The US healthcare conglomerate said the deal was the first in a series of prospective global partnerships to accelerate manufacturing of its experimental COVID-19 vaccine candidate, even before it has a signal that it works. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: